CD 3254 (CAS 196961-43-0)

CD 3254, a synthetic retinoid, exhibits selective modulation of retinoic acid receptors (RARs), particularly favoring the RARβ and RARγ subtypes over RARα. Unlike other retinoids that indiscriminately activate all RAR subtypes, CD 3254′s selectivity allows for more targeted research into the specific roles and mechanisms these receptors play in cellular differentiation, proliferation, and apoptosis. This specificity holds significant promise for elucidating the pathways through which retinoids influence gene expression and cellular processes. In research applications, CD 3254 is utilized to dissect the intricate balance of retinoid activities that underlie various biological phenomena, including embryonic development and the maintenance of epithelial tissues. Its mechanism of action involves altering the transcription of genes that are critical for cell cycle regulation and differentiation, thereby providing useful for investigating the molecular underpinnings of retinoid function and their impact on cellular behavior.